2023

Vancouver, British Columbia and Rehovot, Israel – September 6th, 2023 BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that US sales of its flagship product VINIA® in the month of August have crossed the USD 1Million per month line. This significant milestone marks a new inflection point in BioHarvest’s […]

Vancouver, British Columbia and Rehovot, Israel – August 30, 2023-  BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that it has released Q2 2023 results. Revenue of its flagship VINIA® product reached USD 2.75M, representing 228% growth compared to the same quarter of last year and 27% growth compared

VANCOUVER, CANADA, AND REHOVOT, ISRAEL, August 24, 2023 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) announces that it is hosting the Q2 Performance Update Presentation on Wednesday, September 6, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will be hosted by CEO Ilan Sobel. Mr. Sobel will discuss

VANCOUVER, CANADA, and REHOVOT, ISRAEL, July 18 2023 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) is pleased to announce that it has closed its non-brokered private placement of convertible notes (the “Notes”) previously announced on July 7, 2023. The Company has issued Notes in the aggregate principal amount of

Dr. Brian Cornblatt will give the keynote address on the “HealthConf” Stage at Collision Vancouver, British Columbia, and Rehovot, Israel– (June 27, 2023) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) has been invited to one of the largest and fastest-growing technology conferences in North America. Its Chief Medical Officer,

Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – June 26, 2023) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) announces that it will be participating in the Jefferies Vitamins and Supplements Conference, June 27, in London, England. BioHarvest Sciences CEO Ilan Sobel will be attending this prestigious industry conference as